Clinical Trials Logo

Filter by:
NCT ID: NCT04427332 Completed - covid19 Clinical Trials

Smell and Taste Disorders in COVID-19 Patients

COVID-19 ORL
Start date: June 11, 2020
Phase:
Study type: Observational

This is a prospective monocentric observational study with the aim of investigating the demographic and clinical factors related to the smell and taste disorders in patients with Severe Acute Respiratory Syndrome - Coronavirus - 2 (Sars-Cov-2) infection.

NCT ID: NCT04427072 Completed - Clinical trials for Carcinoma, Non-Small-Cell Lung

Study of Capmatinib Efficacy in Comparison With Docetaxel in Previously Treated Participants With Non-small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation

GeoMETry-III
Start date: September 25, 2020
Phase: Phase 3
Study type: Interventional

The purpose of the study is to learn whether the study drug (capmatinib) helps to control lung cancer better compared to a single agent chemotherapy (docetaxel) and whether it is safe when given to patients suffering from a particular type of lung cancer. This type of cancer is called non-small cell lung cancer (NSCLC) with certain specific genetic alterations (called mutations) of a gene called MET, within a specific part of the gene called exon 14.

NCT ID: NCT04425954 Completed - Pituitary Adenoma Clinical Trials

Evaluation of Early Retinal Vascular Modifications After Endoscopic Endonasal Pituitary Surgery

Start date: January 1, 2019
Phase:
Study type: Observational

This study evaluates the retinal vascular features using optical coherence tomography angiography in patients that received endoscopic endonasal approach for the removal of an intra-suprasellar pituitary adenoma compressing the optic nerve.

NCT ID: NCT04425239 Completed - Clinical trials for Colorectal Cancer Stage IV

Intermittent or Continuous Panitumumab Plus FOLFIRI for RAS/B-RAF Wild-type Metastatic Colorectal Cancer

IMPROVE
Start date: May 21, 2018
Phase: Phase 2
Study type: Interventional

The investigators hypothesize that intermittent first-line Panitumumab plus FOLFIRI is effective as the same regimen given continuously, in unresectable metastatic RAS and BRAF wild type colorectal cancer patients. Correlative studies on tumor and blood samples could identify potential biomarkers of efficacy and help defining personalized treatment strategy.

NCT ID: NCT04424771 Completed - Clinical trials for Post Traumatic Stress Disorder

Post-traumatic Stress Disease in Health Workers During COVID-19 Pandemia

Start date: March 1, 2020
Phase:
Study type: Observational

The purpose of the questionnaire is to find risk factors for the development of post-traumatic stress disease (PTSD) in health workers during COVID-19 pandemy.

NCT ID: NCT04424199 Completed - Brain Disease Clinical Trials

Temporal Disorders in Left and Right Brain-Damaged Patients

Start date: February 1, 2019
Phase:
Study type: Observational

Time is an important function that permeates our everyday activities but it has been so far significantly under-investigated in neurological patients. For instance, it is known that right brain damaged (RBD) patients with spatial attentional deficit (neglect) are impaired in both the ability to estimate the duration of an event (Time Estimation), showing a time underestimation, and the ability of mentally moving in past and future time (Mental Time Travelling), showing a deficit in processing future events when they are projected in the past. After a leftward shift of spatial attention induced by prismatic adaptation (PA), both the underestimation and the ability to travel in time ameliorate. However, less is known about these abilities in left brain damaged (LBD) patients. Aims of this study are to investigate: i) the performance (in terms of accuracy and reaction times) of LBD and RBD patients on Mental Time Travelling; ii) the correlation between Mental Time Travelling and Time Estimation abilities; iii) the efficacy of a single session of PA inducing a leftward (L-PA) and a rightward (R-PA) attentional shift on Mental Time Travelling and Time Estimation abilities. A group of control subjects will be involved for comparison among groups.

NCT ID: NCT04423978 Completed - COVID-19 Clinical Trials

Implications of Covid-19 on the Lifestyle Changes

Start date: May 4, 2020
Phase:
Study type: Observational

Northern Italy has been profoundly touched by the Covid-19 pandemic. To limit the outbreaks of contagion, the Italian government imposed 2.months of complete lock-down, which imposed the social isolation for the whole population and, for those positive to the Covid-19, the complete confinement at home. Despite the recommendations for conserving healthy lifestyle of the Italian Government, during the lock-down the likelihood to fall into unhealthy behaviours might have increased. This study aims to describe the impact of Covid-19 on the lifestyles of a population of Italian adults living in an area of high spread of Sars-CoV-2.

NCT ID: NCT04423302 Completed - Prediabetic State Clinical Trials

Effect of Totum-63 on Glucose and Lipid Homeostasis in Subjects With Dysglycemia (REVERSE-IT)

REVERSE-IT
Start date: July 8, 2020
Phase: N/A
Study type: Interventional

This clinical study aims to assess the efficacy of TOTUM-63, a mix of 5 plant extracts, consumed at the daily regimen of three times per day on glucose and lipid homeostasis in dysglycemic subjects. The hypothesis is that TOTUM-63, consumed 3 times per day, is superior to placebo for decrease of fasting plasma glucose (FPG) concentration after 24 weeks of consumption.

NCT ID: NCT04423016 Completed - Preterm Birth Clinical Trials

Transitional Cerebrovascular Reactivity in Very Preterm Infants

Start date: February 21, 2018
Phase:
Study type: Observational

The transitional period, defined as the first 72 hours after preterm birth, is often characterized by a significant hemodynamic instability and may also be associated with an impairment of cerebral autoregulation, with relevant clinical implications. The moving correlation coefficient between cerebral oxygenation and heart rate, also defined as TOHRx, has been previously proposed as a marker of cerebrovascular reactivity and provides an indirect estimation of cerebral autoregulation in preterm infants. This study aims to evaluate whether different antenatal, perinatal and postnatal factors may influence cerebrovascular reactivity in very preterm infants during the transitional period.

NCT ID: NCT04422262 Completed - Dietary Habits Clinical Trials

Analysis of Long Term Risk of Coronavirus Disease-19 Emergency

ALTRISCOVID-19
Start date: June 8, 2020
Phase:
Study type: Observational

The aim of this study is to investigate dietary, lifestyle and psychosocial changes possibly occurred during Italy's lockdown, that is in the period of time between March 9 2020 and May 3 2020 (hereafter referred to as the Phase 1 lockdown) in two different populations: the Moli-sani Study cohort and the Italian general population.